Health ❯Healthcare ❯Telehealth

Pharmaceuticals

Weight Loss Weight Loss Drugs Weight Loss Medications Patient Safety

Hims & Hers Reports Record Q1 Results While Stock Dips on Cautious Q2 Guidance

The telehealth platform transitions to branded weight-loss medications and sets ambitious 2030 growth targets following a strong start to 2025.

Hims & Hers Expands Weight-Loss Offerings with New Medications